瘦素在二次打击创伤/脓毒症模型中通过IL-6依赖途径降低死亡率和器官功能障碍
研究在小鼠二次打击创伤/脓毒症模型(第一次打击:股骨骨折加失血;第二次打击:2天后盲肠结扎穿孔)中评估瘦素剂量依赖性的治疗作用及IL-6依赖性。69只野生型和63只IL-6小鼠分为创伤/脓毒症组、创伤组和假手术组,每组皮下给予溶媒或瘦素2.5 μg/g(瘦素1)或5 μg/g(瘦素2),首次打击后观察8天。瘦素在脓毒症组呈剂量依赖性抗炎作用,在假手术组部分呈促炎作用;野生型创伤/脓毒症组死亡率随瘦素剂量降低(溶媒组36.4%、瘦素1组25%、瘦素2组0%),而IL-6小鼠脓毒症组死亡率随瘦素剂量升高(53.8%、83.4%、100%)。创伤组和假手术组全部存活。作者认为瘦素可能通过IL-6对创伤后脓毒症结局产生正面影响,可能成为预防或治疗创伤后脓毒症相关不良结局的治疗药物。
要点
- 野生型创伤/脓毒症小鼠死亡率:溶媒组36.4%、瘦素1组(2.5 μg/g)25%、瘦素2组(5 μg/g)0%,呈剂量依赖性降低。
- IL-6小鼠创伤/脓毒症组死亡率随瘦素剂量升高:溶媒组53.8%、瘦素1组83.4%、瘦素2组100%。
- 创伤组和假手术组所有小鼠均存活。
- 野生型创伤/脓毒症小鼠中,瘦素使脾脏CD4和CD8水平升高,并减轻IV型超敏反应(P ≤ 0.039)。
- 瘦素降低肿瘤坏死因子-α和IL-6水平,但未达统计学显著。
适用人群与场景
- 野生型小鼠和IL-6小鼠,二次打击模型:第一次打击为股骨骨折和失血,第二次打击为2天后盲肠结扎穿孔。
- 分组包括创伤/脓毒症组、创伤组(仅第一次打击加开腹)和假手术组(仅开腹)。
处置流程与药物剂量
- 瘦素皮下给药,剂量为2.5 μg/g(瘦素1)或5 μg/g(瘦素2),首次打击后观察8天。
- 对照组给予溶媒。
研究设计与关键结果
- 研究类型为动物实验(小鼠二次打击创伤/脓毒症模型),样本量为69只野生型小鼠和63只IL-6小鼠。
- 野生型创伤/脓毒症组死亡率:溶媒组36.4%、瘦素1组25%、瘦素2组0%,呈剂量依赖性降低。
- IL-6小鼠创伤/脓毒症组死亡率:溶媒组53.8%、瘦素1组83.4%、瘦素2组100%,呈剂量依赖性升高。
- 创伤组和假手术组所有小鼠均存活。
- 野生型创伤/脓毒症小鼠中,瘦素使脾脏CD4和CD8水平升高,IV型超敏反应减轻(P ≤ 0.039)。
- 瘦素降低肿瘤坏死因子-α和IL-6水平,但未达统计学显著。
证据类型、等级与局限
- 证据类型:动物实验(小鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,瘦素通过IL-6对创伤和脓毒症小鼠的结局似乎有正面影响,且预防性使用时未对医疗状况产生负面影响,瘦素可能是预防或治疗初始创伤后脓毒症相关不良结局的治疗药物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Leptin is thought to play an important role in the regulation of the immune system. In patients, leptin is inversely proportional to interleukin-6 (IL-6) levels. Thus, the objective of our study was to evaluate a dose-dependent therapeutic impact of leptin with possible IL-6-dependency on immune actions and outcome in a trauma/sepsis model.
MATERIALS AND METHODS: Sixty-nine wild-type and 63 IL-6 mice were subdivided into three groups: trauma/sepsis group (first hit: femur fracture and hemorrhage; second hit: cecal ligation and puncture 2 days later), trauma group (first hit and laparotomy), sham group (laparotomy only). Each group received vehicle or leptin (2.5 μg/g (leptin1) or 5 μg/g (leptin2)) subcutaneously and was observed for 8 days after induction of the first hit. Mortality, humoral, and cellular immune markers were determined.
RESULTS: We revealed a dose-dependent anti-inflammatory effect of exogenous leptin in the sepsis groups and to some extent a pro-inflammatory effect in the sham groups. Leptin administration resulted in a decreased mortality in septic wild-type mice (trauma/sepsis vehicle group: 36.4%, trauma/sepsis leptin1 group: 25%, trauma/sepsis leptin2 group: 0%) and in an increased mortality in septic IL-6 mice (53.8%, 83.4%, 100%). All mice of the trauma groups and sham groups survived. In wild-type trauma/sepsis mice, exogenous leptin led to increased levels of CD4 and CD8 in the spleen, and a less pronounced type IV hypersensitivity (P ≤ 0.039). Furthermore, it decreased the levels of tumor necrosis factor-α and IL-6, not reaching statistical significance.
CONCLUSIONS: Due to the fact that leptin administration to traumatized and septic mice seems to have a positive effect on their outcome via IL-6 and does not negatively impact their medical condition if applied preventively, leptin might be a therapeutic agent for the prevention, or treatment of sepsis-related detrimental outcome after initial trauma.
参考来源
- Negrin LL, Jahn A, van Griensven M, et al. Leptin Protects Against Mortality and Organ Dysfunction in A Two-Hit Trauma/Sepsis Model and is IL-6-Dependent. Shock. 2017. PMID: 28114167. doi:10.1097/SHK.0000000000000837
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。